"The study relied on information posted on state and the District of Columbia pharmacy board web sites and the responses to a detailed questionnaire. Eight states including Alabama, Delaware, Florida, Georgia and Ohio never bothered to respond."

Walter F. Roche Jr. at meningitis-etc.blogspot.com points out in his aticle: 

Study: States Ignore New Federal Compounding Law

meningitis-etc.blogspot.com/2016/.../study-states-ignore-new-federal.ht...